News for Guardant Health, Inc. (GH.MX)

Bank of America has increased its price target for Guardant Health (GH) to $60, up from the previous target of $56, while maintaining a Buy rating on the compan

Summary Guardant Health Inc (GH), a prominent player in the precision oncology sector, has announced that it will release its financial results for the first qu

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the first quarter 2025 after mar

Guardant Health Inc (GH), a leader in precision oncology, announced a strategic partnership with Bayshore HealthCare, a prominent Canadian home and community he

Shares of Guardant Health Inc (GH) surged 3.09% in mid-day trading on Mar 22. The stock reached an intraday high of $46.39, before settling at $46.10, up fr

Shares of Guardant Health Inc (GH) surged 0.22% in mid-day trading on Mar 21. The stock reached an intraday high of $45.55, before settling at $44.82, up fr

Shares of Guardant Health Inc (GH) fell 4.16% in mid-day trading on Mar 13. The stock reached an intraday low of $39.72, before recovering slightly to $41.31,

Guardant Health has an expanding pipeline that could significantly boost its future market potential. Check out my recommendation for GH stock.

Shares of Guardant Health Inc (GH) surged 5.04% in mid-day trading on Mar 12. The stock reached an intraday high of $45.00, before settling at $44.78, up fr

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the Centers for Medicare & Medicaid Services (CMS) has approved Advan

Guardant Health Inc (GH), a prominent player in precision oncology, announced on February 11, 2025, the approval of restricted stock units (RSUs) and stock opti

Guardant Health Inc (GH), a leader in precision oncology, has released findings from its second annual "Closing the Gap: CRC Screening Insights" survey, conduct

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the results of the second annual ”œClosing the Gap: CRC Screening In

Shares of Guardant Health Inc (GH) surged 7.88% in mid-day trading on Feb 26. The stock reached an intraday high of $43.83, before settling at $43.51, up fr

Shares of Guardant Health Inc (GH) fell 9.56% in mid-day trading on Feb 23. The stock reached an intraday low of $42.19, before recovering slightly to $42.91,

Guardant Health Inc (GH), a leader in precision oncology, announced its financial results for the fourth quarter and full year ending December 31, 2024. The com

Call Start: 16:30 January 1, 0000 5:31 PM ETGuardant Health, Inc.

The following slide deck was published by Guardant Health, Inc.

On December 31, 2024, Deep Track Capital, LP (Trades, Portfolio) made a significant move by acquiring an additional 1,949,942 shares of enGene Holdings Inc (ENG